Tech Company Financing Transactions

Remedy Pharmaceuticals Funding Round

Private investors invested in a $500 thousand funding round for Remedy Pharmaceuticals. The financing round was announced on 11/22/2011.

Transaction Overview

Announced On
11/22/2011
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing - amended.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
233 Bdwy. 1750
New York, NY 10279
USA
Email Address
Overview
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
Profile
Remedy Pharmaceuticals LinkedIn Company Profile
Social Media
Remedy Pharmaceuticals Company Twitter Account
Company News
Remedy Pharmaceuticals News
Facebook
Remedy Pharmaceuticals on Facebook
YouTube
Remedy Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
David Geliebter
  David Geliebter LinkedIn Profile  David Geliebter Twitter Account  David Geliebter News  David Geliebter on Facebook
Chief Executive Officer
Sven Jacobson
  Sven Jacobson LinkedIn Profile  Sven Jacobson Twitter Account  Sven Jacobson News  Sven Jacobson on Facebook
VP - R & D
Thomas MacAllister
  Thomas MacAllister LinkedIn Profile  Thomas MacAllister Twitter Account  Thomas MacAllister News  Thomas MacAllister on Facebook
VP - Regulatory Affairs
Ann Tunstall
  Ann Tunstall LinkedIn Profile  Ann Tunstall Twitter Account  Ann Tunstall News  Ann Tunstall on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/22/2011: ExactTarget venture capital transaction
Next: 11/22/2011: SoluLink venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary